Please login to the form below
equity, diversity and inclusivity
This page shows the latest equity, diversity and inclusivity news and features for those working in and with pharma, biotech and healthcare.
Latest Intelligence
-
ASH 2022: bad blood but big advances
ASH’s own booth included a ‘Health Equity Studio’, a space designed to help recognise inequities in healthcare and provide tools to make change. ... Long may it continue. And may we extend that to all other forms of diversity, equity and inclusivity
-
Impact That Matters
By looking at equity, diversity and inclusivity (ED&I) in our own agency, we’re ensuring that our work has the right impact on the right people. ... Digital inspiration for pharma on mobile, social media, strategy, best practice, regulations and more.
-
Health For All
By Claire Knapp and Cath Brassington-Richards. Havas Lynx Group, a global healthcare communications agency, has been working closely with people who are taking action for equity, diversity and inclusivity (EDI) ... how overlooked patient populations can
More from intelligence
Approximately 1 fully matching, plus 2 partially matching documents found.
Subscribe to our email news alerts
-
Pharmacovigilance Manager
- Highly competitive salary
-
Technical Sales Representative
- Highly competitive salary
-
Pharmacovigilance Project Lead
- Highly competitive salary
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
-
Senior Medical Writer
- Highly competitive salary
- Strategy Director - Healthcare Advertising
- £90,000 - £120,000 yearly
- Associate Director - Global Healthcare Consulting
- £100,000 - £115,000 yearly
- FDA proposes improvements for oncology clinical trials supporting accelerated approval
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- AstraZeneca’s mild combination asthma reliever approved in UK
- Eli Lilly increases investment to almost $1bn for new Irish manufacturing facility
- Merck reports positive results for Keytruda plus chemotherapy in endometrial cancer
- AstraZeneca/MSD’s Lynparza combination approved in UK for prostate cancer
- Bristol Myers Squibb’s Sotyktu approved by EC for plaque psoriasis
- Positive results for Almirall’s lebrikizumab in atopic dermatitis published in NEJM and BJD
- When to call in the specialists: strategy in Medical Affairs
- Time to talk about health inequalities
- Powering Rapid Cognitive Analysis with AI
- AstraZeneca and Amgen’s Tezspire recommended by NICE for severe asthma
PMHub
OPEN Health
OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health...
Latest intelligence
- Time to talk about health inequalities
- Health inequalities are increasingly being recognised as a crucial healthcare challenge in the UK...
- The speed of science and the pace of comms
- Pharma red tape slows comms but there is a solution, Paul Hutchings, founder of fox&cat, writes....
- Improving cardiovascular disease care and awareness
- Scott Curley talks to PME about the risks of CVD and the importance of getting the right treatment at the right time...
